$Utime (WTO.US)$ Expecting FDA approval.[Grin] As part of UT...
Expecting FDA approval.
As part of UTime's global vaccine market entry strategy, particularly focusing on the development of the mpox (monkeypox) vaccine.
Bowen Therapeutics is conducting research on the mpox virus and UTime has stated that it has developed a promising hexavalent recombinant protein vaccine. UTime is overseeing ongoing clinical trials and future vaccine development, with the aim of expediting FDA approval.
Bowen Therapeutics is conducting research on the mpox virus and UTime has stated that it has developed a promising hexavalent recombinant protein vaccine. UTime is overseeing ongoing clinical trials and future vaccine development, with the aim of expediting FDA approval.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment